PRESS RELEASE published on 03/14/2025 at 17:45, 1 year 2 months ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics lance un processus de recherche de repreneurs dans le cadre de son redressement judiciaire. Appel d'offres ouvert jusqu'au 11 avril 2025 Appel D'offres Redressement Judiciaire Repreneurs Procédure PHAXIAM Therapeutics
BRIEF published on 03/06/2025 at 18:01, 1 year 2 months ago PHAXIAM Therapeutics entre en redressement judiciaire et retarde ses résultats financiers Retard Des Résultats Financiers Administrateur Judiciaire Suspension Des Échanges Mise Sous Séquestre De PHAXIAM Défis Biotechnologiques
BRIEF published on 03/06/2025 at 18:01, 1 year 2 months ago PHAXIAM Therapeutics Enters Receivership and Delays Financial Results Trading Suspension Financial Results Delay PHAXIAM Receivership Biotech Challenges Court-appointed Administrator
PRESS RELEASE published on 03/06/2025 at 17:56, 1 year 2 months ago Informations privilégiées / Autres communiqués PHAXIAM annonce l'ouverture d'une procédure de redressement judiciaire et le report de la publication de ses résultats financiers 2024. La Société se place sous la protection du Tribunal de commerce de Lyon Résultats Financiers Tribunal De Commerce Redressement Judiciaire PHAXIAM Procédure
PRESS RELEASE published on 03/06/2025 at 17:56, 1 year 2 months ago Inside Information / Other news releases PHAXIAM Therapeutics announces the opening of a receivership procedure and postponement of its 2024 financial results publication. The company continues operations under observation period Financial Results Biopharmaceutical Company PHAXIAM Therapeutics Receivership Procedure Phage-based Treatments
BRIEF published on 03/06/2025 at 11:45, 1 year 2 months ago Suspension de la Cotation de PHAXIAM Therapeutics Euronext Paris Biopharmaceutique Suspension Cotation PHAXIAM Therapeutics Infections Résistantes
BRIEF published on 03/06/2025 at 11:45, 1 year 2 months ago Suspension of the Listing of PHAXIAM Therapeutics Euronext Paris Biopharmaceutical PHAXIAM Therapeutics Suspension Of Quotation Resistant Infections
PRESS RELEASE published on 03/06/2025 at 11:40, 1 year 2 months ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics suspend sa cotation sur Euronext Paris en attendant un prochain communiqué. La société développe des traitements innovants contre les infections bactériennes Cotation Suspension Traitements Innovants PHAXIAM Therapeutics Infections Bactériennes
BRIEF published on 12/30/2024 at 17:50, 1 year 4 months ago PHAXIAM Therapeutics: Promising results from the PhagoDAIR pilot study Infection Control PHAXIAM Therapeutics Phase II GLORIA PhagoDAIR Study Anti-S. Aureus Phages
BRIEF published on 12/30/2024 at 17:50, 1 year 4 months ago PHAXIAM Therapeutics : résultats prometteurs de l’étude pilote PhagoDAIR PHAXIAM Therapeutics Étude PhagoDAIR Phages Anti-S. Aureus Phase II GLORIA Contrôle De L'infection
Published on 05/26/2026 at 14:30, 8 minutes ago Klondike Gold Announces 2026 Diamond Drilling Program Underway to Update and Expand Gold Mineral Resources
Published on 05/26/2026 at 14:15, 23 minutes ago Worksport (NASDAQ:WKSP) Secures U.S. Patent For 'Industry-First' Zerofrost Heat Pump Through Its Subsidiary, Terravis Energy
Published on 05/26/2026 at 14:00, 38 minutes ago Ameriwest Critical Metals Provides Q2 2026 Corporate Update and Announces Live CEO Investor Webinar
Published on 05/26/2026 at 13:50, 48 minutes ago Sun Peak Metals Confirms Strong VMS And Orogenic Gold Potential Across Newly Acquired Round 9 Licenses in Saudi Arabia
Published on 05/26/2026 at 13:45, 53 minutes ago Quartz Completes Phase 4 Drilling with Assays Pending at Maestro Gold-Silver Project, British Columbia
Published on 05/26/2026 at 14:15, 23 minutes ago Siegfried successfully places senior bonds of CHF 200 million
Published on 05/26/2026 at 13:33, 1 hour 5 minutes ago Changes on the Executive Board of Hapag-Lloyd AG
Published on 05/26/2026 at 13:25, 1 hour 13 minutes ago Coinsilium Group Limited: Coinsilium Backed Otomato Unveils UK Technology Venture Builder Improbable as its new Strategic Investor
Published on 05/26/2026 at 13:25, 1 hour 13 minutes ago FAIR PLAY MENARINI INTERNATIONAL AWARD: HONOURING THREE YOUNG CHAMPIONS OF COURAGE AND HUMANITY
Published on 05/26/2026 at 13:10, 1 hour 28 minutes ago Eli Lilly to Acquire HBM Portfolio Company Curevo for up to USD 1.5 Billion
Published on 05/26/2026 at 07:59, 6 hours 39 minutes ago Saint-Gobain signe un accord de cession de son activité de distribution de carrelage dans les pays nordiques
Published on 05/26/2026 at 07:59, 6 hours 39 minutes ago Saint-Gobain has signed an agreement for the sale of its Tiles Distribution business in the Nordics
Published on 05/25/2026 at 18:00, 20 hours 38 minutes ago Déclaration des transactions sur actions propres réalisées du 18/05/2026 au 24/05/2026
Published on 05/25/2026 at 17:45, 20 hours 53 minutes ago Déclaration hebdomadaire de rachat d'actions
